Welcome to our first Pα+ Quarterly Briefing! Every three months, our Founder & Editor Josh Hardman will walk you through major developments from the prior quarter across drug development, policy and regulatory, science and academia, and much more. He closes with a look ahead to the next quarter, so you know what to look out for. This first Briefing, covering Q1 2026, includes Compass Pathways’…
